| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | retinoic acid binding | 1.46e-06 | 28 | 142 | 5 | GO:0001972 | |
| GeneOntologyMolecularFunction | fatty acid binding | 9.65e-06 | 69 | 142 | 6 | GO:0005504 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 1.14e-05 | 107 | 142 | 7 | GO:0033293 | |
| GeneOntologyMolecularFunction | retinoid binding | 2.27e-05 | 48 | 142 | 5 | GO:0005501 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 2.51e-05 | 49 | 142 | 5 | GO:0019840 | |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 1.08e-04 | 35 | 142 | 4 | GO:0015020 | |
| GeneOntologyBiologicalProcess | estrogen catabolic process | 1.04e-08 | 5 | 141 | 4 | GO:0006711 | |
| GeneOntologyBiologicalProcess | phenylpropanoid catabolic process | 3.11e-08 | 6 | 141 | 4 | GO:0046271 | |
| GeneOntologyBiologicalProcess | coumarin catabolic process | 3.11e-08 | 6 | 141 | 4 | GO:0046226 | |
| GeneOntologyBiologicalProcess | flavone metabolic process | 3.11e-08 | 6 | 141 | 4 | GO:0051552 | |
| GeneOntologyBiologicalProcess | phenylpropanoid metabolic process | 4.26e-07 | 10 | 141 | 4 | GO:0009698 | |
| GeneOntologyBiologicalProcess | coumarin metabolic process | 4.26e-07 | 10 | 141 | 4 | GO:0009804 | |
| GeneOntologyBiologicalProcess | flavonoid metabolic process | 1.43e-06 | 13 | 141 | 4 | GO:0009812 | |
| GeneOntologyBiologicalProcess | flavonoid glucuronidation | 3.10e-06 | 5 | 141 | 3 | GO:0052696 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 1.14e-05 | 21 | 141 | 4 | GO:0052695 | |
| GeneOntologyBiologicalProcess | hormone catabolic process | 1.14e-05 | 21 | 141 | 4 | GO:0042447 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 2.78e-05 | 26 | 141 | 4 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 2.78e-05 | 26 | 141 | 4 | GO:0006063 | |
| GeneOntologyBiologicalProcess | pigment metabolic process | 4.56e-05 | 94 | 141 | 6 | GO:0042440 | |
| GeneOntologyBiologicalProcess | calcium-dependent cell-matrix adhesion | 4.64e-05 | 2 | 141 | 2 | GO:0016340 | |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 6.58e-05 | 12 | 141 | 3 | GO:0052697 | |
| GeneOntologyBiologicalProcess | steroid catabolic process | 8.27e-05 | 34 | 141 | 4 | GO:0006706 | |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR2G2 OR5A1 OR10G7 OR10G4 TAS2R42 TAS2R13 OR14A2 OR1D5 SCNN1D TAS2R45 OR10G9 OR4K3 OR4K15 | 9.97e-05 | 547 | 141 | 13 | GO:0007606 |
| GeneOntologyBiologicalProcess | tetrapyrrole catabolic process | 1.08e-04 | 14 | 141 | 3 | GO:0033015 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR2G2 OR5A1 OR10G7 OR10G4 TAS2R42 TAS2R13 OR14A2 OR1D5 TAS2R45 OR10G9 OR4K3 OR4K15 | 1.28e-04 | 485 | 141 | 12 | GO:0050907 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR2G2 OR5A1 OR10G7 OR10G4 TAS2R42 TAS2R13 OR14A2 OR1D5 TAS2R45 OR10G9 OR4K3 OR4K15 | 2.61e-04 | 524 | 141 | 12 | GO:0009593 |
| GeneOntologyBiologicalProcess | sensory perception | COL4A3 PDYN OR2G2 OR5A1 OR10G7 OR10G4 TAS2R42 COL18A1 TAS2R13 OR14A2 PGAP1 OR1D5 SCNN1D TAS2R45 OR10G9 FTO OR4K3 OR4K15 | 3.81e-04 | 1072 | 141 | 18 | GO:0007600 |
| GeneOntologyBiologicalProcess | vesicle transport along microtubule | 4.08e-04 | 51 | 141 | 4 | GO:0047496 | |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 4.39e-04 | 52 | 141 | 4 | GO:0008210 | |
| MousePheno | abnormal lateral ventricle morphology | 2.58e-06 | 164 | 100 | 9 | MP:0000823 | |
| MousePheno | enlarged brain ventricles | 1.57e-05 | 156 | 100 | 8 | MP:0011380 | |
| MousePheno | abnormal brain ventricle size | 2.25e-05 | 164 | 100 | 8 | MP:0013229 | |
| MousePheno | abnormal brain ventricle morphology | CCNO DAG1 TRIM71 ATXN1L ADGRA2 THAP11 COL18A1 CLCN3 PKD1 HYDIN | 3.75e-05 | 286 | 100 | 10 | MP:0000822 |
| Domain | Myelin_TF | 3.86e-07 | 3 | 137 | 3 | IPR013681 | |
| Domain | MYT1 | 3.86e-07 | 3 | 137 | 3 | PF08474 | |
| Domain | Znf_C2HC | 7.60e-06 | 6 | 137 | 3 | IPR002515 | |
| Domain | zf-C2HC | 7.60e-06 | 6 | 137 | 3 | PF01530 | |
| Domain | ZF_CCHHC | 1.32e-05 | 7 | 137 | 3 | PS51802 | |
| Domain | UDPGT | 1.51e-05 | 21 | 137 | 4 | PF00201 | |
| Domain | UDPGT | 1.51e-05 | 21 | 137 | 4 | PS00375 | |
| Domain | UDP_glucos_trans | 1.51e-05 | 21 | 137 | 4 | IPR002213 | |
| Domain | Leu-rich_rpt | LRRC63 FBXL13 LRRC10 ADGRA2 FBXL4 TLR10 TRIL PKD1 PHLPP2 LRRC74B | 3.19e-05 | 271 | 137 | 10 | IPR001611 |
| Domain | Traffickng_kinesin-bd_prot_dom | 5.34e-05 | 2 | 137 | 2 | IPR022154 | |
| Domain | Milton | 5.34e-05 | 2 | 137 | 2 | PF12448 | |
| Domain | ARHGEF5_35 | 5.34e-05 | 2 | 137 | 2 | PF15441 | |
| Domain | ARHGEF5/35_N | 5.34e-05 | 2 | 137 | 2 | IPR029212 | |
| Domain | WD40 | 1.26e-04 | 259 | 137 | 9 | PF00400 | |
| Domain | - | LRRC63 FBXL13 LRRC10 ADGRA2 FBXL4 TLR10 TRIL PKD1 PHLPP2 LRRC74B | 1.31e-04 | 321 | 137 | 10 | 3.80.10.10 |
| Domain | L_dom-like | LRRC63 FBXL13 LRRC10 ADGRA2 FBXL4 TLR10 TRIL PKD1 PHLPP2 LRRC74B | 1.56e-04 | 328 | 137 | 10 | IPR032675 |
| Domain | HAP1_N | 1.59e-04 | 3 | 137 | 2 | IPR006933 | |
| Domain | HAP1_N | 1.59e-04 | 3 | 137 | 2 | PF04849 | |
| Domain | WD40 | 1.63e-04 | 268 | 137 | 9 | SM00320 | |
| Domain | WD40_repeat | 1.82e-04 | 272 | 137 | 9 | IPR001680 | |
| Domain | SIAH-type | 2.02e-04 | 16 | 137 | 3 | IPR013323 | |
| Domain | WD_REPEATS_1 | 2.15e-04 | 278 | 137 | 9 | PS00678 | |
| Domain | WD_REPEATS_2 | 2.20e-04 | 279 | 137 | 9 | PS50082 | |
| Domain | WD_REPEATS_REGION | 2.20e-04 | 279 | 137 | 9 | PS50294 | |
| Domain | LRR_8 | 2.70e-04 | 171 | 137 | 7 | PF13855 | |
| Domain | LRR_TYP | 3.33e-04 | 177 | 137 | 7 | SM00369 | |
| Domain | Leu-rich_rpt_typical-subtyp | 3.33e-04 | 177 | 137 | 7 | IPR003591 | |
| Domain | WD40_repeat_dom | 3.49e-04 | 297 | 137 | 9 | IPR017986 | |
| Domain | LRR | 7.13e-04 | 201 | 137 | 7 | PS51450 | |
| Domain | Alpha_kinase | 7.86e-04 | 6 | 137 | 2 | PF02816 | |
| Domain | MHCK_EF2_kinase | 7.86e-04 | 6 | 137 | 2 | IPR004166 | |
| Domain | ALPHA_KINASE | 7.86e-04 | 6 | 137 | 2 | PS51158 | |
| Domain | Alpha_kinase | 7.86e-04 | 6 | 137 | 2 | SM00811 | |
| Domain | - | 7.94e-04 | 333 | 137 | 9 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 8.29e-04 | 335 | 137 | 9 | IPR015943 | |
| Domain | TAS2R | 8.87e-04 | 26 | 137 | 3 | PF05296 | |
| Domain | T2R | 8.87e-04 | 26 | 137 | 3 | IPR007960 | |
| Domain | LRR_1 | 1.18e-03 | 219 | 137 | 7 | PF00560 | |
| Domain | WD40_repeat_CS | 1.33e-03 | 164 | 137 | 6 | IPR019775 | |
| Domain | zf-TRAF | 1.45e-03 | 8 | 137 | 2 | PF02176 | |
| Domain | NHL_repeat_subgr | 1.86e-03 | 9 | 137 | 2 | IPR013017 | |
| Domain | NHL_repeat | 2.31e-03 | 10 | 137 | 2 | IPR001258 | |
| Domain | NHL | 2.31e-03 | 10 | 137 | 2 | PF01436 | |
| Domain | - | 2.91e-03 | 39 | 137 | 3 | 2.120.10.30 | |
| Domain | MFS_dom | 3.09e-03 | 134 | 137 | 5 | IPR020846 | |
| Domain | OA_transporter | 3.36e-03 | 12 | 137 | 2 | IPR004156 | |
| Domain | Znf_TRAF | 3.36e-03 | 12 | 137 | 2 | IPR001293 | |
| Domain | Quinoprot_gluc/sorb_DH | 3.36e-03 | 12 | 137 | 2 | IPR011041 | |
| Domain | OATP | 3.36e-03 | 12 | 137 | 2 | PF03137 | |
| Domain | G-protein_beta_WD-40_rep | 3.54e-03 | 85 | 137 | 4 | IPR020472 | |
| Domain | ZF_TRAF | 3.95e-03 | 13 | 137 | 2 | PS50145 | |
| Domain | - | 3.95e-03 | 13 | 137 | 2 | 2.10.10.10 | |
| Domain | NHL | 3.95e-03 | 13 | 137 | 2 | PS51125 | |
| Domain | Cys-rich_flank_reg_C | 4.35e-03 | 90 | 137 | 4 | IPR000483 | |
| Domain | LRRCT | 4.35e-03 | 90 | 137 | 4 | SM00082 | |
| Domain | FN_type2_col-bd | 4.59e-03 | 14 | 137 | 2 | IPR000562 | |
| Domain | FN2_2 | 4.59e-03 | 14 | 137 | 2 | PS51092 | |
| Domain | - | 4.59e-03 | 14 | 137 | 2 | 3.90.890.10 | |
| Domain | FN2_1 | 4.59e-03 | 14 | 137 | 2 | PS00023 | |
| Domain | fn2 | 4.59e-03 | 14 | 137 | 2 | PF00040 | |
| Domain | FN2 | 4.59e-03 | 14 | 137 | 2 | SM00059 | |
| Domain | 6-blade_b-propeller_TolB-like | 4.66e-03 | 46 | 137 | 3 | IPR011042 | |
| Domain | Ig_E-set | 7.24e-03 | 104 | 137 | 4 | IPR014756 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 1.15e-05 | 41 | 103 | 5 | M7399 | |
| Pathway | WP_ESTROGEN_METABOLISM | 1.78e-05 | 22 | 103 | 4 | MM15888 | |
| Pathway | REACTOME_ASPIRIN_ADME | 1.83e-05 | 45 | 103 | 5 | MM15694 | |
| Pathway | REACTOME_GLUCURONIDATION | 2.55e-05 | 24 | 103 | 4 | MM14599 | |
| Pathway | REACTOME_GLUCURONIDATION | 3.02e-05 | 25 | 103 | 4 | M17787 | |
| Pathway | WP_GLUCURONIDATION | 3.02e-05 | 25 | 103 | 4 | MM15820 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 3.02e-05 | 25 | 103 | 4 | M605 | |
| Pathway | WP_GLUCURONIDATION | 3.55e-05 | 26 | 103 | 4 | M39404 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 3.74e-05 | 52 | 103 | 5 | M14171 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 4.81e-05 | 28 | 103 | 4 | M19580 | |
| Pathway | WP_CODEINE_AND_MORPHINE_METABOLISM | 1.30e-04 | 14 | 103 | 3 | M39328 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | 1.57e-04 | 70 | 103 | 5 | MM14984 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 1.82e-04 | 39 | 103 | 4 | MM15695 | |
| Pathway | REACTOME_ASPIRIN_ADME | 2.91e-04 | 44 | 103 | 4 | M45014 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | 4.82e-04 | 190 | 103 | 7 | MM15687 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 5.16e-04 | 51 | 103 | 4 | M17726 | |
| Pathway | REACTOME_RHOT1_GTPASE_CYCLE | 5.21e-04 | 5 | 103 | 2 | M41820 | |
| Pathway | WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME | 6.73e-04 | 145 | 103 | 6 | M45512 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 6.89e-04 | 55 | 103 | 4 | M14933 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION | 8.92e-04 | 153 | 103 | 6 | MM15844 | |
| Pubmed | 4.32e-09 | 6 | 145 | 4 | 32527940 | ||
| Pubmed | 4.32e-09 | 6 | 145 | 4 | 20297805 | ||
| Pubmed | Genome-wide association of serum bilirubin levels in Korean population. | 6.98e-09 | 17 | 145 | 5 | 20639394 | |
| Pubmed | Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37. | 1.00e-08 | 7 | 145 | 4 | 8467709 | |
| Pubmed | 1.00e-08 | 7 | 145 | 4 | 8464825 | ||
| Pubmed | 1.00e-08 | 7 | 145 | 4 | 27514509 | ||
| Pubmed | 2.00e-08 | 8 | 145 | 4 | 20610558 | ||
| Pubmed | 2.00e-08 | 8 | 145 | 4 | 18052087 | ||
| Pubmed | 2.00e-08 | 8 | 145 | 4 | 17179145 | ||
| Pubmed | 3.59e-08 | 9 | 145 | 4 | 22511988 | ||
| Pubmed | 5.97e-08 | 10 | 145 | 4 | 23642732 | ||
| Pubmed | 5.97e-08 | 10 | 145 | 4 | 11465080 | ||
| Pubmed | 5.97e-08 | 10 | 145 | 4 | 23371916 | ||
| Pubmed | A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. | 5.97e-08 | 10 | 145 | 4 | 22558097 | |
| Pubmed | 7.10e-08 | 3 | 145 | 3 | 12847094 | ||
| Pubmed | 7.10e-08 | 3 | 145 | 3 | 29519853 | ||
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | 1.40e-07 | 12 | 145 | 4 | 20308471 | |
| Pubmed | 1.40e-07 | 12 | 145 | 4 | 19419973 | ||
| Pubmed | Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. | 1.40e-07 | 12 | 145 | 4 | 11434514 | |
| Pubmed | UGT1A1 is a major locus influencing bilirubin levels in African Americans. | 2.01e-07 | 13 | 145 | 4 | 22085899 | |
| Pubmed | Genome-wide analysis of hepatic lipid content in extreme obesity. | 2.01e-07 | 13 | 145 | 4 | 25246029 | |
| Pubmed | 2.81e-07 | 14 | 145 | 4 | 21646302 | ||
| Pubmed | Human UDP-glucuronosyltransferases: metabolism, expression, and disease. | 2.81e-07 | 14 | 145 | 4 | 10836148 | |
| Pubmed | 2.81e-07 | 14 | 145 | 4 | 9295054 | ||
| Pubmed | Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. | 2.81e-07 | 14 | 145 | 4 | 14672974 | |
| Pubmed | Myt/NZF family transcription factors regulate neuronal differentiation of P19 cells. | 2.83e-07 | 4 | 145 | 3 | 21540077 | |
| Pubmed | 2.83e-07 | 4 | 145 | 3 | 17558305 | ||
| Pubmed | Genome-wide association meta-analysis for total serum bilirubin levels. | 5.07e-07 | 16 | 145 | 4 | 19414484 | |
| Pubmed | 7.05e-07 | 5 | 145 | 3 | 20565459 | ||
| Pubmed | 7.05e-07 | 5 | 145 | 3 | 15057901 | ||
| Pubmed | 8.48e-07 | 18 | 145 | 4 | 20056724 | ||
| Pubmed | A genome-wide assessment of variability in human serum metabolism. | 1.07e-06 | 19 | 145 | 4 | 23281178 | |
| Pubmed | 1.41e-06 | 6 | 145 | 3 | 24214099 | ||
| Pubmed | Genetic determinants influencing human serum metabolome among African Americans. | 2.89e-06 | 24 | 145 | 4 | 24625756 | |
| Pubmed | Family-based genome-wide association scan of attention-deficit/hyperactivity disorder. | 5.85e-06 | 9 | 145 | 3 | 20732626 | |
| Pubmed | 1.14e-05 | 11 | 145 | 3 | 18695635 | ||
| Pubmed | Hnf1b controls pancreas morphogenesis and the generation of Ngn3+ endocrine progenitors. | 1.54e-05 | 36 | 145 | 4 | 25715395 | |
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 11677206 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 11919560 | ||
| Pubmed | Studies on the substrate specificity of human intestinal UDP- lucuronosyltransferases 1A8 and 1A10. | 1.73e-05 | 2 | 145 | 2 | 10497143 | |
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 20230862 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 12944498 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 25653102 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 17529886 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 33802342 | ||
| Pubmed | Analysis of transcriptional activity by the Myt1 and Myt1l transcription factors. | 1.73e-05 | 2 | 145 | 2 | 29291346 | |
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 25547628 | ||
| Pubmed | Ubiquitin-specific protease 34 in macrophages limits CD8 T cell-mediated onset of vitiligo in mice. | 1.73e-05 | 2 | 145 | 2 | 37043976 | |
| Pubmed | Pathogenicity analysis of novel variations in Chinese Han patients with polycystic kidney disease. | 1.73e-05 | 2 | 145 | 2 | 28578020 | |
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 11901093 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 35354796 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 17244605 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 22031623 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 18568343 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 36293397 | ||
| Pubmed | Human UGT1A8 and UGT1A10 mRNA are expressed in primary human hepatocytes. | 1.73e-05 | 2 | 145 | 2 | 17603215 | |
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 15709193 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 9647757 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 20089735 | ||
| Pubmed | 1.97e-05 | 13 | 145 | 3 | 15938754 | ||
| Pubmed | 4.62e-05 | 17 | 145 | 3 | 17928203 | ||
| Pubmed | 5.04e-05 | 95 | 145 | 5 | 20568250 | ||
| Pubmed | Characterization of PKD protein-positive exosome-like vesicles. | 5.16e-05 | 3 | 145 | 2 | 19158352 | |
| Pubmed | Function of endogenous inhibitors of angiogenesis as endothelium-specific tumor suppressors. | 5.16e-05 | 3 | 145 | 2 | 15710885 | |
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 16636344 | ||
| Pubmed | Glucuronidation of psilocin and 4-hydroxyindole by the human UDP-glucuronosyltransferases. | 5.16e-05 | 3 | 145 | 2 | 20007669 | |
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 19244109 | ||
| Pubmed | Myt1 and Myt1l transcription factors limit proliferation in GBM cells by repressing YAP1 expression. | 5.16e-05 | 3 | 145 | 2 | 30312684 | |
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 19225446 | ||
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 17406868 | ||
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 29656931 | ||
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 19996319 | ||
| Pubmed | Trak1 mutation disrupts GABA(A) receptor homeostasis in hypertonic mice. | 5.16e-05 | 3 | 145 | 2 | 16380713 | |
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 19364970 | ||
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 23721685 | ||
| Pubmed | Analysis of the polycystin complex (PCC) in human urinary exosome-like vesicles (ELVs). | 5.16e-05 | 3 | 145 | 2 | 32001768 | |
| Pubmed | TRAK/Milton motor-adaptor proteins steer mitochondrial trafficking to axons and dendrites. | 5.16e-05 | 3 | 145 | 2 | 23395375 | |
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 26247833 | ||
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 21278488 | ||
| Pubmed | Expression of polycystins and fibrocystin on primary cilia of lung cells. | 5.16e-05 | 3 | 145 | 2 | 25367197 | |
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 17339869 | ||
| Pubmed | Differences in UGT1A1, UGT1A7, and UGT1A9 polymorphisms between Uzbek and Japanese populations. | 5.16e-05 | 3 | 145 | 2 | 24453052 | |
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 23789755 | ||
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 37845212 | ||
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 16397224 | ||
| Pubmed | 5.63e-05 | 407 | 145 | 9 | 12693553 | ||
| Pubmed | 8.12e-05 | 105 | 145 | 5 | 9628581 | ||
| Pubmed | Loss of Zeb2 in mesenchyme-derived nephrons causes primary glomerulocystic disease. | 8.93e-05 | 21 | 145 | 3 | 27591083 | |
| Pubmed | 8.93e-05 | 21 | 145 | 3 | 10761934 | ||
| Pubmed | Human metabolic individuality in biomedical and pharmaceutical research. | 9.64e-05 | 57 | 145 | 4 | 21886157 | |
| Pubmed | 1.03e-04 | 4 | 145 | 2 | 18946804 | ||
| Pubmed | 1.03e-04 | 4 | 145 | 2 | 15644324 | ||
| Pubmed | 1.03e-04 | 4 | 145 | 2 | 9271343 | ||
| Pubmed | 1.03e-04 | 4 | 145 | 2 | 23700788 | ||
| Pubmed | Chromosomal mapping of a human phenol UDP-glucuronosyltransferase, GNT1. | 1.03e-04 | 4 | 145 | 2 | 2108603 | |
| Pubmed | 1.03e-04 | 4 | 145 | 2 | 32475690 | ||
| Pubmed | Loss of oriented cell division does not initiate cyst formation. | 1.03e-04 | 4 | 145 | 2 | 19959710 | |
| Pubmed | Genetic mapping of the mouse neuromuscular mutation kyphoscoliosis. | 1.03e-04 | 4 | 145 | 2 | 7774920 | |
| Pubmed | 1.03e-04 | 4 | 145 | 2 | 20147615 | ||
| Pubmed | The atypical Rho GTPases Miro-1 and Miro-2 have essential roles in mitochondrial trafficking. | 1.03e-04 | 4 | 145 | 2 | 16630562 | |
| Cytoband | 2q37 | 4.35e-08 | 31 | 143 | 5 | 2q37 | |
| Cytoband | 16q22.2 | 4.36e-05 | 22 | 143 | 3 | 16q22.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q37 | 8.11e-05 | 226 | 143 | 6 | chr2q37 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16q22 | 2.84e-04 | 183 | 143 | 5 | chr16q22 | |
| GeneFamily | Zinc fingers C2H2C-type | 1.50e-07 | 3 | 97 | 3 | 1261 | |
| GeneFamily | WD repeat domain containing | 1.16e-05 | 262 | 97 | 9 | 362 | |
| GeneFamily | UDP glucuronosyltransferases | 2.49e-05 | 32 | 97 | 4 | 363 | |
| GeneFamily | TNF receptor associated factors | 5.88e-04 | 7 | 97 | 2 | 1056 | |
| GeneFamily | Taste 2 receptors | 1.19e-03 | 39 | 97 | 3 | 1162 | |
| GeneFamily | Collagens | 1.92e-03 | 46 | 97 | 3 | 490 | |
| GeneFamily | Olfactory receptors, family 10 | 5.36e-03 | 66 | 97 | 3 | 157 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 5.36e-03 | 66 | 97 | 3 | 722 | |
| GeneFamily | Solute carriers | 5.37e-03 | 395 | 97 | 7 | 752 | |
| GeneFamily | F-box and leucine rich repeat proteins | 5.60e-03 | 21 | 97 | 2 | 558 | |
| ToppCell | COVID-19_Mild-Neu_0|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients | 5.43e-08 | 63 | 143 | 6 | 1ab77b6f098686bc168427159282bbf3538d4292 | |
| ToppCell | facs-Spleen-nan-24m-Myeloid|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-07 | 156 | 143 | 7 | 034d4359359a44c205c6931f38a375271ac2752b | |
| ToppCell | facs-Spleen-nan-24m-Myeloid-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-07 | 156 | 143 | 7 | 2a4dac4100c0339aad4905b8eaca6e8fe806718b | |
| ToppCell | facs-Spleen-nan-24m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-07 | 156 | 143 | 7 | 21267718d3a3dc19988663b6846aed8bb3eae836 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.41e-07 | 156 | 143 | 7 | abea3c183d32062b009a79a2bdf861021989c7ef | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-06 | 184 | 143 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-06 | 184 | 143 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-06 | 184 | 143 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | COVID-19-kidney-DCT|kidney / Disease (COVID-19 only), tissue and cell type | 2.57e-06 | 188 | 143 | 7 | df1fd0819d301679f3c9ea404e942e39095912eb | |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.28e-06 | 195 | 143 | 7 | 9d649ac7d2af313481069c95349efc0c68449e2b | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Mesenchymal-Mesoderm|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 3.87e-06 | 200 | 143 | 7 | 0f4b8b0868bda406fe6bf01d1b722510fdfd0168 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-1m-Neuroepithelial|1m / Sample Type, Dataset, Time_group, and Cell type. | 3.87e-06 | 200 | 143 | 7 | fe15fb050852c187f6f17fb4f6172e69fe7d74a4 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-1m-Neuroepithelial-Proteoglycan-expressing_cell|1m / Sample Type, Dataset, Time_group, and Cell type. | 3.87e-06 | 200 | 143 | 7 | d0a4c3bf9c5211defb4c1d0b6653833cccbd29ee | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-05 | 157 | 143 | 6 | 370f44047ef438b8f1124c2c2761c150c0d8c57f | |
| ToppCell | droplet-Spleen-nan-3m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-05 | 170 | 143 | 6 | dbd6c9c7be824a1ff1b31af791064127cafbd194 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-stromal_related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.18e-05 | 175 | 143 | 6 | b8995e7ada85ba959f06264a0295b61e390c4e6c | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-stromal_related-T_reticular|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.18e-05 | 175 | 143 | 6 | 7ae76bd3b4f610b2f98716a4456437cd3696b686 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Myeloid-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-05 | 176 | 143 | 6 | d687e6c3f9043f2574d072f815b8c2258f9dc7b5 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Myeloid|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-05 | 176 | 143 | 6 | 4f37854124d77ee64dcb40fd491eaed2ba389891 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Myeloid-microglial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-05 | 176 | 143 | 6 | 0afba8707b847e5bdf6f38fe4379967631fe2240 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-05 | 177 | 143 | 6 | c9e8149639551a4c8daa90fcb2b895fdcff2e2ba | |
| ToppCell | COVID-19_Moderate-B_memory|World / disease group, cell group and cell class | 2.56e-05 | 180 | 143 | 6 | 2f37187b866edb56410c2334b72713f2248dc335 | |
| ToppCell | COVID-19_Moderate-B_memory|COVID-19_Moderate / disease group, cell group and cell class | 2.72e-05 | 182 | 143 | 6 | bbdbef62389ac062118cc0c7979686393399f2c8 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_memory-B_memory-3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.98e-05 | 185 | 143 | 6 | 91c9a3ea1afd97d35bd05648875d29b35fe09128 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_memory-B_memory-3|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.98e-05 | 185 | 143 | 6 | 05e6eb78ead81268c1656e7ffe34f9cb7329b908 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.08e-05 | 186 | 143 | 6 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.17e-05 | 187 | 143 | 6 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | Control-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | 3.17e-05 | 187 | 143 | 6 | 4e64be635f445276e71f2937f33f041c3a4204ab | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_memory-B_memory-3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.27e-05 | 188 | 143 | 6 | cd833a125a5279ac32a9a9cb9ecd05ae24bea3a9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.36e-05 | 189 | 143 | 6 | f51cdc9a47371cab8ed9ae63a6f14da07ede446c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.36e-05 | 189 | 143 | 6 | 975c0f079903ae36b0ffa54e86294d42ec7697de | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.36e-05 | 189 | 143 | 6 | 7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-bronchial_smooth_muscle_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-05 | 189 | 143 | 6 | 4dc32b463546bbe7250dddd281b92ad17ec22da1 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Airway_Smooth_Muscle|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-05 | 189 | 143 | 6 | 0d06bf0d7191d13a1c4f30a7881e7ea1093bfd6f | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_memory|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.57e-05 | 191 | 143 | 6 | 22134a2c1a92208bc1629a620ce73a56502613c2 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_memory-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.67e-05 | 192 | 143 | 6 | debd471f61cf3606b8e9c246add0be5df601af7f | |
| ToppCell | COVID-19_Mild-Lymphoid_B-B_memory|COVID-19_Mild / Disease group, lineage and cell class | 3.67e-05 | 192 | 143 | 6 | d27db7669de95bddbea8ccb83e6f10ae7240b1ab | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_memory|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.67e-05 | 192 | 143 | 6 | 314f74dd3c6d94839eed05b9a1a398217ef78029 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.78e-05 | 193 | 143 | 6 | e2b455387d1de7812305200a2041a0f4759a6f54 | |
| ToppCell | COVID-19-kidney-Fibroblast-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.01e-05 | 195 | 143 | 6 | 3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-B-B_memory|COVID-19_Mild / Disease, condition lineage and cell class | 4.48e-05 | 199 | 143 | 6 | 54e392b4ebe601d4838739ff7de3ac6b2203c948 | |
| ToppCell | Sigmoid-(5)_Dendritic_cell-(51)_cDC1|Sigmoid / shred on region, Cell_type, and subtype | 4.61e-05 | 200 | 143 | 6 | 4ce0a2238c90622e41fd86ac4b7d82adf4af2c3b | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Myeloid-Granulocytic_cells-Mast-cells|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.61e-05 | 200 | 143 | 6 | 0b02f3ca3d8612ed7af46381195b0ed5591313cf | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.61e-05 | 200 | 143 | 6 | ae91dc047dc80560ba298d8d21a772154fa2775d | |
| ToppCell | Sigmoid-Dendritic_cell-cDC1|Sigmoid / Region, Cell class and subclass | 4.61e-05 | 200 | 143 | 6 | 3523ec986e8c9e176e08836c974b1de8b56d8b16 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.61e-05 | 200 | 143 | 6 | ac8a5d71acd4d401995babd233f0d3738e8ad2a5 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2|Control_saline / Treatment groups by lineage, cell group, cell type | 4.61e-05 | 200 | 143 | 6 | bc8949eb34482aca166c4602ff6ab876cb4c2c3c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.52e-05 | 135 | 143 | 5 | 7b456fa9a5f5ce58976a8f1fad18c0f96a096930 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Granulocytic-Neutrophil|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.02e-04 | 144 | 143 | 5 | 1efa434e577d1f87e02df01667782f414d63bd60 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Granulocytic-Neutrophil-Neutrophil_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.02e-04 | 144 | 143 | 5 | c0c5f254a960ba5e5f1354599d54e77360e6c2ac | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 145 | 143 | 5 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-04 | 148 | 143 | 5 | 18cfecd6ae20edb74f5d44ba759909df356acf3a | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_monocytic|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.31e-04 | 152 | 143 | 5 | 072daae0deb6cb92f126e4566f1d264cda9ed157 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.40e-04 | 154 | 143 | 5 | c6ecc46b99a783373729f7fae0b23216148ffb78 | |
| ToppCell | Substantia_nigra-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Igfbp2_(Igfbp2)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.41e-04 | 82 | 143 | 4 | 89aff8676f98e062d0e69b38c7184e51aa1a915e | |
| ToppCell | Substantia_nigra-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Igfbp2_(Igfbp2)--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.41e-04 | 82 | 143 | 4 | 6875a10abf1221b3dfd954c319b5e8e12fac1ff2 | |
| ToppCell | Substantia_nigra-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Igfbp2_(Igfbp2)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.41e-04 | 82 | 143 | 4 | 259bb4ae0373d8352cb1c3bff08f66b89a298440 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.48e-04 | 156 | 143 | 5 | 60f1ce38e34b582f589db1e0d6139282c1902b2b | |
| ToppCell | facs-Spleen-nan-3m-Myeloid|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-04 | 156 | 143 | 5 | f532ef4e92ac7661b1a8a4f2e98d80ce8d4e3655 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-04 | 156 | 143 | 5 | 4d2679e7639758c49fc25a2deb9109b08f0a3e57 | |
| ToppCell | facs-Spleen-nan-3m-Myeloid-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-04 | 156 | 143 | 5 | da4f35353a84d919e683554932f110e29568df33 | |
| ToppCell | facs-Spleen-nan-3m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-04 | 156 | 143 | 5 | f1e25ff85c5f2f8555f9fb5ae5daed7ddb418fd1 | |
| ToppCell | droplet-Spleen-nan-24m-Myeloid-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 158 | 143 | 5 | e1a8dba5a88bc3ce112829c5ecb112cbbee5b078 | |
| ToppCell | droplet-Spleen-nan-24m-Myeloid|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 158 | 143 | 5 | 72e4f8ae137a7dddee0dc6236532e0711065e6af | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l15|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.62e-04 | 159 | 143 | 5 | 999f30c7273ed77b34537621bcfcc7fc30121138 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular-6|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.62e-04 | 159 | 143 | 5 | 655c0749c238bd68cb797adb83e25a23b8a3cc9d | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.72e-04 | 161 | 143 | 5 | 5fba13f0aa5002f7eefe219e2c6a07e163f1a50d | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.77e-04 | 162 | 143 | 5 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | Bronchial_Biopsy-Immune-Neutrophils|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.77e-04 | 162 | 143 | 5 | 985adca17b0c99563feef7910f3da5df31e636b6 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.87e-04 | 164 | 143 | 5 | d167c7a987b9b35d1e7725c803df4f9cd5380e47 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.93e-04 | 165 | 143 | 5 | 436ce4bc75e1ba4351c439ccad19f84ad5bcb92f | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.93e-04 | 165 | 143 | 5 | 242bdb7654f415391fb8e9bdc06412c7eee9c97e | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-maDC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.93e-04 | 165 | 143 | 5 | 1c3709ac9f96ace1f3b28e1f2f15b4a8d65885ca | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-maDC-maDC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.93e-04 | 165 | 143 | 5 | fbc7d97e6f30975d35c76a7c97947a34cf5975d2 | |
| ToppCell | droplet-Spleen-nan-24m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-04 | 165 | 143 | 5 | 3cdb921f5b9facf04f81995d5641ac14ef3dbb6f | |
| ToppCell | droplet-Spleen-nan-21m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-04 | 167 | 143 | 5 | cfcd72292c733cdb18c92fdb61b68f6806d22c8c | |
| ToppCell | droplet-Heart-nan-18m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-04 | 168 | 143 | 5 | 2201ae834b53cbdc085f8f02607fa5b5bd911268 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.10e-04 | 168 | 143 | 5 | d19a115365c5415e51c039718d7669de788fcf33 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.11e-04 | 91 | 143 | 4 | b0658e020f80e56fab9d2aa07e321d9b33d7af2c | |
| ToppCell | facs-Marrow-Granulocytes-24m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-04 | 169 | 143 | 5 | f38b52972a6c492ce2fd520a26bb3fc8db23bf85 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-04 | 169 | 143 | 5 | 5320da1d61806b53e0bd96bbdfdb8fd69246681b | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-04 | 169 | 143 | 5 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.15e-04 | 169 | 143 | 5 | a84490724a206c9bbb145f7ce08613f91d100ac4 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.21e-04 | 170 | 143 | 5 | 09bcbc7eb3b1d35cf03f01ce2f2fe37373382dd4 | |
| ToppCell | Endothelial-B-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 2.27e-04 | 171 | 143 | 5 | 07ff7059071da83da1d8f266a586573920d75b58 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.34e-04 | 172 | 143 | 5 | 858cee96c1c06160863b4adcd7023c0d678bd50f | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Colon_normal_tissue|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.34e-04 | 172 | 143 | 5 | 94842346c84542a5243bd765e49f4af8bc5182db | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Colon_normal_tissue-Colon_normal_tissue|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.34e-04 | 172 | 143 | 5 | 5d654dd030ed22a701e15c5f09002951d99a52e8 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.40e-04 | 173 | 143 | 5 | 0c74bdb40e635d906fd180412c23bf7fed61621e | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-04 | 173 | 143 | 5 | 2415b6ff49f334da570577d4e93484d024a3dbd5 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_12|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.40e-04 | 173 | 143 | 5 | a55f310c533432e9e26e400026a5b47245152976 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_12|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.40e-04 | 173 | 143 | 5 | 9c7386bf0a899882c733f0b4921a96afde032a7d | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-04 | 173 | 143 | 5 | 2acd0693a2dfe04e3c1b2125ea63efe92d13150b | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.60e-04 | 176 | 143 | 5 | dee780cfa85234a7cd7bf440b66b84cec959893e | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.67e-04 | 177 | 143 | 5 | 3a150dcaefa342d49968b42c7cdb1fbb633adcd0 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.67e-04 | 177 | 143 | 5 | c9e5820ff0bc7ad1adcfb2651713fdfc58bced56 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-04 | 178 | 143 | 5 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | C_00|World / shred on cell type and cluster | 2.81e-04 | 179 | 143 | 5 | da2dadc3266ffebd4a34ac61bfa05fddcadcde4c | |
| ToppCell | PBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.96e-04 | 181 | 143 | 5 | 2b9b460239d67fd480cee60820cdb306109d3567 | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.96e-04 | 181 | 143 | 5 | fcc94f04dae98b817ec06b282d2e887804d37ae5 | |
| Drug | naringenin chalcone | 6.62e-09 | 5 | 139 | 4 | ctd:C027329 | |
| Drug | anthrarobin | 6.62e-09 | 5 | 139 | 4 | ctd:C032186 | |
| Drug | 1,2,5,8-tetrahydroxy anthraquinone | 1.98e-08 | 6 | 139 | 4 | ctd:C543211 | |
| Drug | alloin | 1.98e-08 | 6 | 139 | 4 | ctd:C006457 | |
| Drug | 2',5'-dihydroxychalcone | 1.98e-08 | 6 | 139 | 4 | ctd:C107497 | |
| Drug | sulforaphane nitrile | 2.26e-08 | 15 | 139 | 5 | CID000543743 | |
| Drug | 2',4'-dihydroxychalcone | 4.59e-08 | 7 | 139 | 4 | ctd:C059354 | |
| Drug | 1,4-dihydroxyanthraquinone | 9.14e-08 | 8 | 139 | 4 | ctd:C034890 | |
| Drug | Benzamidoxime hydrochloride | 1.48e-07 | 21 | 139 | 5 | CID000069186 | |
| Drug | AC1MRQNQ | 1.64e-07 | 9 | 139 | 4 | CID003522271 | |
| Drug | DHPASiU | 1.64e-07 | 9 | 139 | 4 | CID000197602 | |
| Drug | 3-iodophenol | 1.64e-07 | 9 | 139 | 4 | CID000012272 | |
| Drug | AC1L4J7U | 1.64e-07 | 9 | 139 | 4 | CID000186631 | |
| Drug | Chebi:32663 | 1.64e-07 | 9 | 139 | 4 | CID005460873 | |
| Drug | silibinin | COL4A3 COL6A3 PDE4C SLCO2B1 UGT1A10 UGT1A8 UGT1A7 UGT1A9 COL18A1 NFKB2 GSTCD PRKCZ | 1.91e-07 | 285 | 139 | 12 | CID000005213 |
| Drug | phenanthridine | 2.43e-07 | 23 | 139 | 5 | CID000009189 | |
| Drug | 2,6-dihydroxyanthraquinone | 2.72e-07 | 10 | 139 | 4 | ctd:C034889 | |
| Drug | AS-3201 | 3.05e-07 | 24 | 139 | 5 | CID000153948 | |
| Drug | 5,6-benzoquinoline | 3.80e-07 | 25 | 139 | 5 | CID000006796 | |
| Drug | 4-nitrophenyl)imidazole | 4.25e-07 | 11 | 139 | 4 | CID000123155 | |
| Drug | AC1O5XMV | 4.25e-07 | 11 | 139 | 4 | CID006442661 | |
| Drug | retigabine | 4.62e-07 | 48 | 139 | 6 | CID000121892 | |
| Drug | N-OH-DABZ | 6.34e-07 | 12 | 139 | 4 | CID000051366 | |
| Drug | 1-O-beta-D-glucopyranosyl-D-mannitol | 6.34e-07 | 12 | 139 | 4 | CID000088735 | |
| Drug | 4-hydroxyestrone | 6.34e-07 | 12 | 139 | 4 | ctd:C026418 | |
| Drug | 2,4,6-TCB | 6.34e-07 | 12 | 139 | 4 | CID000037247 | |
| Drug | nonanoyl-N-methylglucamide | 6.34e-07 | 12 | 139 | 4 | CID000160090 | |
| Drug | 7,7,7-triphenylheptanoic acid | 6.34e-07 | 12 | 139 | 4 | CID000276709 | |
| Drug | erucin | 6.93e-07 | 28 | 139 | 5 | CID000078160 | |
| Drug | iberin | 8.33e-07 | 29 | 139 | 5 | CID000010455 | |
| Drug | hydratropic acid | 8.87e-07 | 4 | 139 | 3 | ctd:C013025 | |
| Drug | 2-vanillin | 8.87e-07 | 4 | 139 | 3 | ctd:C060843 | |
| Drug | diphenylacetic acid | 8.87e-07 | 4 | 139 | 3 | ctd:C037760 | |
| Drug | 2-hydroxyestrone | 9.11e-07 | 13 | 139 | 4 | ctd:C024980 | |
| Drug | tritanol | 9.11e-07 | 13 | 139 | 4 | CID000006457 | |
| Drug | 5-azido-UDP-glucuronic acid | 9.11e-07 | 13 | 139 | 4 | CID003081279 | |
| Drug | cotinine-N-glucuronide | 9.11e-07 | 13 | 139 | 4 | CID000000411 | |
| Drug | alizarin | 9.11e-07 | 13 | 139 | 4 | ctd:C010078 | |
| Drug | dihydroartemisinin | 9.94e-07 | 30 | 139 | 5 | CID000107770 | |
| Drug | PCB 156 | 1.18e-06 | 31 | 139 | 5 | CID000038019 | |
| Drug | propranolol glucuronide | 1.27e-06 | 14 | 139 | 4 | CID000119515 | |
| Drug | PCB-61 | 1.27e-06 | 14 | 139 | 4 | CID000036401 | |
| Drug | geniposide | 1.63e-06 | 33 | 139 | 5 | CID000107848 | |
| Drug | 2,2',3,5,5'-pentachlorobiphenyl | 1.72e-06 | 15 | 139 | 4 | CID000040469 | |
| Drug | afloqualone | 1.72e-06 | 15 | 139 | 4 | CID000002040 | |
| Drug | naphthyl sulphate | 1.72e-06 | 15 | 139 | 4 | CID000114775 | |
| Drug | coumarin-3-carboxylic acid | 1.72e-06 | 15 | 139 | 4 | CID000010752 | |
| Drug | bergamottin | 1.72e-06 | 15 | 139 | 4 | ctd:C068337 | |
| Drug | isovaleric acid | 2.21e-06 | 5 | 139 | 3 | ctd:C008216 | |
| Drug | biphenylylacetic acid | 2.21e-06 | 5 | 139 | 3 | ctd:C012776 | |
| Drug | quercetin-3,4'-diglucoside | 2.29e-06 | 16 | 139 | 4 | CID005320835 | |
| Drug | 1'-hydroxyestragole | 2.29e-06 | 16 | 139 | 4 | CID000040003 | |
| Drug | bilirubin-phosphate | 2.29e-06 | 16 | 139 | 4 | CID005497144 | |
| Drug | muraglitazar | 2.55e-06 | 36 | 139 | 5 | CID000206044 | |
| Drug | glucoraphanin | 2.55e-06 | 36 | 139 | 5 | CID000656556 | |
| Drug | bevirimat | 2.55e-06 | 36 | 139 | 5 | CID000457928 | |
| Drug | acotiamide | 2.94e-06 | 37 | 139 | 5 | CID005282338 | |
| Drug | Phloretin | 2.94e-06 | 37 | 139 | 5 | ctd:D010693 | |
| Drug | 3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one | 2.98e-06 | 17 | 139 | 4 | CID000003573 | |
| Drug | 6-hydroxychrysene | 2.98e-06 | 17 | 139 | 4 | CID000037766 | |
| Drug | ethoxytriethyleneglycol | 3.12e-06 | 66 | 139 | 6 | CID000008190 | |
| Drug | pregnenolone-16 alpha-carbonitrile | 3.41e-06 | 67 | 139 | 6 | CID000015032 | |
| Drug | AC1MRGT8 | 3.41e-06 | 67 | 139 | 6 | CID003517815 | |
| Drug | SureCN12722713 | 3.81e-06 | 18 | 139 | 4 | CID005488034 | |
| Drug | ethyl-beta-D-6-glucosiduronic acid | 3.81e-06 | 18 | 139 | 4 | CID000152226 | |
| Drug | Br 2 | 3.81e-06 | 18 | 139 | 4 | CID003060900 | |
| Drug | 2,3,7-trichlorodibenzo-p-dioxin | 3.81e-06 | 18 | 139 | 4 | CID000036614 | |
| Drug | ApApG | 3.81e-06 | 18 | 139 | 4 | CID003081975 | |
| Drug | C1 11-32 | 3.81e-06 | 18 | 139 | 4 | CID000443077 | |
| Drug | C11131 | 3.81e-06 | 18 | 139 | 4 | CID000443076 | |
| Drug | thymoquinone | 4.37e-06 | 40 | 139 | 5 | CID000010281 | |
| Drug | 3-phenylpropionic acid | 4.39e-06 | 6 | 139 | 3 | ctd:C035253 | |
| Drug | Indoprofen | 4.39e-06 | 6 | 139 | 3 | ctd:D007216 | |
| Drug | 9-OH-risperidone | 4.80e-06 | 19 | 139 | 4 | CID000475100 | |
| Drug | 5alpha-spirostan-3beta-ol | 4.80e-06 | 19 | 139 | 4 | CID000091433 | |
| Drug | almokalant | 4.80e-06 | 19 | 139 | 4 | CID003033962 | |
| Drug | eugenol | 5.65e-06 | 73 | 139 | 6 | CID000003314 | |
| Drug | tectochrysin | 5.97e-06 | 20 | 139 | 4 | CID005281954 | |
| Drug | AC1L1OBF | 5.97e-06 | 20 | 139 | 4 | CID000032736 | |
| Drug | 4'-hydroxydiclofenac | 5.97e-06 | 20 | 139 | 4 | CID000116545 | |
| Drug | entacapone | 5.97e-06 | 20 | 139 | 4 | ctd:C071192 | |
| Drug | N-hydroxy-PhIP | 6.30e-06 | 43 | 139 | 5 | CID000104954 | |
| Drug | 7,8-benzoquinoline | 6.30e-06 | 43 | 139 | 5 | CID000009191 | |
| Drug | Tranilast sodium | 6.87e-06 | 115 | 139 | 7 | CID000005527 | |
| Drug | estriol-16-glucuronide | 7.34e-06 | 21 | 139 | 4 | CID000122281 | |
| Drug | dulcin | 7.34e-06 | 21 | 139 | 4 | CID000009013 | |
| Drug | amonafide | 8.93e-06 | 22 | 139 | 4 | CID000050515 | |
| Drug | N-methylpiperazine | 8.93e-06 | 22 | 139 | 4 | CID000053167 | |
| Drug | plumbagin | 8.93e-06 | 22 | 139 | 4 | ctd:C014758 | |
| Drug | amidoxime | 1.08e-05 | 23 | 139 | 4 | CID000465967 | |
| Drug | estradiol-3-glucuronide | 1.08e-05 | 23 | 139 | 4 | CID000066651 | |
| Drug | 1-hydroxypyrene | 1.09e-05 | 48 | 139 | 5 | CID000021387 | |
| Drug | salicylamide | 1.09e-05 | 48 | 139 | 5 | CID000005147 | |
| Drug | glabridin | 1.22e-05 | 8 | 139 | 3 | ctd:C107601 | |
| Drug | phenanthroline | 1.34e-05 | 50 | 139 | 5 | CID000067473 | |
| Drug | (+/-)-Abacavir | 1.48e-05 | 51 | 139 | 5 | CID000001971 | |
| Drug | Finrazole | 1.48e-05 | 51 | 139 | 5 | CID000178036 | |
| Drug | 5-MOP | 1.52e-05 | 25 | 139 | 4 | CID000002355 | |
| Drug | Hymecromone | 1.52e-05 | 25 | 139 | 4 | ctd:D006923 | |
| Drug | AzMC | 1.52e-05 | 25 | 139 | 4 | CID000064986 | |
| Disease | N-acetyl-4-chlorophenylalanine measurement | 2.09e-09 | 5 | 135 | 4 | EFO_0801060 | |
| Disease | 5-hydroxyindole sulfate measurement | 2.09e-09 | 5 | 135 | 4 | EFO_0800085 | |
| Disease | nuclear receptor subfamily 1 group D member 2 measurement | 2.09e-09 | 5 | 135 | 4 | EFO_0801853 | |
| Disease | X-21339 measurement | 1.45e-08 | 7 | 135 | 4 | EFO_0800808 | |
| Disease | X-11793--oxidized bilirubin measurement | 2.89e-08 | 8 | 135 | 4 | EFO_0021260 | |
| Disease | Succinimide measurement | 2.89e-08 | 8 | 135 | 4 | EFO_0022118 | |
| Disease | X-11530 measurement | 2.89e-08 | 8 | 135 | 4 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 2.89e-08 | 8 | 135 | 4 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 2.89e-08 | 8 | 135 | 4 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 2.89e-08 | 8 | 135 | 4 | EFO_0800696 | |
| Disease | X-10458 measurement | 2.89e-08 | 8 | 135 | 4 | EFO_0800692 | |
| Disease | X-24849 measurement | 2.89e-08 | 8 | 135 | 4 | EFO_0800909 | |
| Disease | serum N-desmethylclozapine measurement | 2.89e-08 | 8 | 135 | 4 | EFO_0600043 | |
| Disease | plasma clozapine measurement | 2.89e-08 | 8 | 135 | 4 | EFO_0600038 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 2.89e-08 | 8 | 135 | 4 | EFO_0802740 | |
| Disease | X-16946 measurement | 2.89e-08 | 8 | 135 | 4 | EFO_0800766 | |
| Disease | X-11442 measurement | 5.19e-08 | 9 | 135 | 4 | EFO_0021236 | |
| Disease | X-11441 measurement | 5.19e-08 | 9 | 135 | 4 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 5.19e-08 | 9 | 135 | 4 | EFO_0004739 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 5.19e-08 | 9 | 135 | 4 | EFO_0801037 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 5.19e-08 | 9 | 135 | 4 | EFO_0801036 | |
| Disease | X-11880 measurement | 5.19e-08 | 9 | 135 | 4 | EFO_0800698 | |
| Disease | protein-tyrosine kinase 6 measurement | 5.19e-08 | 9 | 135 | 4 | EFO_0020691 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 5.19e-08 | 9 | 135 | 4 | EFO_0802127 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 5.19e-08 | 9 | 135 | 4 | EFO_0004570, GO_0009410 | |
| Disease | bilirubin measurement, response to tenofovir | 8.61e-08 | 10 | 135 | 4 | EFO_0004570, EFO_0009279 | |
| Disease | X-21448 measurement | 8.61e-08 | 10 | 135 | 4 | EFO_0800816 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 8.61e-08 | 10 | 135 | 4 | EFO_0802185 | |
| Disease | X-23974 measurement | 8.61e-08 | 10 | 135 | 4 | EFO_0800867 | |
| Disease | indole-3-carboxylate measurement | 9.37e-08 | 3 | 135 | 3 | EFO_0800043 | |
| Disease | blood 4-oxo-retinoic acid measurement | 9.37e-08 | 3 | 135 | 3 | EFO_0022216 | |
| Disease | pregnenetriol sulfate measurement | 1.35e-07 | 11 | 135 | 4 | EFO_0800586 | |
| Disease | plasma N-desmethylclozapine measurement | 1.35e-07 | 11 | 135 | 4 | EFO_0600039 | |
| Disease | histidine betaine (hercynine) measurement | 1.35e-07 | 11 | 135 | 4 | EFO_0800972 | |
| Disease | X-21796 measurement | 1.35e-07 | 11 | 135 | 4 | EFO_0800825 | |
| Disease | insomnia, bilirubin measurement | 1.35e-07 | 11 | 135 | 4 | EFO_0004570, EFO_0004698 | |
| Disease | aldosterone measurement | 1.35e-07 | 11 | 135 | 4 | EFO_0010219 | |
| Disease | p-cresol glucuronide measurement | 2.02e-07 | 12 | 135 | 4 | EFO_0800079 | |
| Disease | biliverdin measurement | 2.02e-07 | 12 | 135 | 4 | EFO_0021033 | |
| Disease | pregnenetriol disulfate measurement | 2.90e-07 | 13 | 135 | 4 | EFO_0800587 | |
| Disease | retinol dehydrogenase 16 measurement | 2.90e-07 | 13 | 135 | 4 | EFO_0802007 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 9.52e-07 | 17 | 135 | 4 | EFO_0004611, EFO_0007800 | |
| Disease | X-21441 measurement | 9.52e-07 | 17 | 135 | 4 | EFO_0800814 | |
| Disease | angiopoietin-related protein 1 measurement | 1.22e-06 | 18 | 135 | 4 | EFO_0801382 | |
| Disease | 3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) measurement | 1.85e-06 | 6 | 135 | 3 | EFO_0800566 | |
| Disease | thyroxine measurement | 2.32e-06 | 83 | 135 | 6 | EFO_0005130 | |
| Disease | tissue factor measurement | 2.36e-06 | 21 | 135 | 4 | EFO_0010623 | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 5.36e-06 | 147 | 135 | 7 | DOID:9352 (biomarker_via_orthology) | |
| Disease | neuroblastoma, cutaneous melanoma | 7.88e-06 | 28 | 135 | 4 | EFO_0000389, EFO_0000621 | |
| Disease | xanthurenate measurement | 9.11e-06 | 29 | 135 | 4 | EFO_0010551 | |
| Disease | response to dolutegravir | 1.05e-05 | 30 | 135 | 4 | EFO_0600017 | |
| Disease | indoleacetate measurement | 1.10e-05 | 10 | 135 | 3 | EFO_0021015 | |
| Disease | vitamin D deficiency | 2.46e-05 | 37 | 135 | 4 | EFO_0003762 | |
| Disease | X-24588 measurement | 2.59e-05 | 13 | 135 | 3 | EFO_0800898 | |
| Disease | hormone measurement | 4.30e-05 | 84 | 135 | 5 | EFO_0004730 | |
| Disease | cholelithiasis | 5.38e-05 | 88 | 135 | 5 | EFO_0004799 | |
| Disease | vitamin D measurement, COVID-19 | 7.57e-05 | 49 | 135 | 4 | EFO_0004631, MONDO_0100096 | |
| Disease | gallstones | 1.42e-04 | 108 | 135 | 5 | EFO_0004210 | |
| Disease | urate measurement, spine bone mineral density | 1.47e-04 | 58 | 135 | 4 | EFO_0004531, EFO_0007701 | |
| Disease | serum gamma-glutamyl transferase measurement | TRIM46 PDE4C TRPM7 UGT1A10 UGT1A8 UGT1A7 UGT1A9 TRIL TRANK1 ZNF827 SLC24A2 PKD1 PKHD1 | 3.00e-04 | 914 | 135 | 13 | EFO_0004532 |
| Disease | Colorectal Carcinoma | SFRP1 HK3 TRPM7 RNPEPL1 SLC22A15 CUBN NDST3 ARAP3 PKHD1 PRKCZ CD300E | 3.97e-04 | 702 | 135 | 11 | C0009402 |
| Disease | neurodegenerative disease (implicated_via_orthology) | 5.55e-04 | 145 | 135 | 5 | DOID:1289 (implicated_via_orthology) | |
| Disease | urate measurement, bone density | WDR7 BAZ2B UGT1A10 UGT1A8 UGT1A7 PDYN TBC1D2 UGT1A9 FBXL4 FTO | 5.79e-04 | 619 | 135 | 10 | EFO_0003923, EFO_0004531 |
| Disease | pulse pressure measurement | TRAF7 USP34 COL6A3 NEK6 TRPM7 WDR7 MYT1 TRAK1 TRANK1 ZNF827 PKD1 FTO ST18 NUP160 HYDIN SOS2 | 6.44e-04 | 1392 | 135 | 16 | EFO_0005763 |
| Disease | bilirubin measurement | 1.01e-03 | 442 | 135 | 8 | EFO_0004570 | |
| Disease | Alcohol Use Disorder | 1.08e-03 | 44 | 135 | 3 | C0001956 | |
| Disease | cortical surface area measurement | USP34 SFRP1 FBXL13 BAZ2B MYT1 TRIM71 CPED1 ADGRA2 BLVRA PKD1 PKHD1 PRKCZ AGBL1 TANGO6 SOS2 | 1.29e-03 | 1345 | 135 | 15 | EFO_0010736 |
| Disease | dodecanedioate measurement | 1.33e-03 | 12 | 135 | 2 | EFO_0021054 | |
| Disease | bronchopulmonary dysplasia (is_implicated_in) | 1.57e-03 | 13 | 135 | 2 | DOID:11650 (is_implicated_in) | |
| Disease | Fibrosis | 1.57e-03 | 50 | 135 | 3 | C0016059 | |
| Disease | Cirrhosis | 1.57e-03 | 50 | 135 | 3 | C1623038 | |
| Disease | trimethylamine-N-oxide measurement | 1.82e-03 | 14 | 135 | 2 | EFO_0010541 | |
| Disease | rostral middle frontal gyrus volume measurement | 1.82e-03 | 14 | 135 | 2 | EFO_0010328 | |
| Disease | abdominal adipose tissue measurement | 1.86e-03 | 53 | 135 | 3 | EFO_0803316 | |
| Disease | Prostatic Neoplasms | 2.17e-03 | 616 | 135 | 9 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 2.17e-03 | 616 | 135 | 9 | C0376358 | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 2.39e-03 | 16 | 135 | 2 | DOID:0110861 (implicated_via_orthology) | |
| Disease | hyperglycemia (implicated_via_orthology) | 2.70e-03 | 17 | 135 | 2 | DOID:4195 (implicated_via_orthology) | |
| Disease | tea consumption measurement | 2.97e-03 | 129 | 135 | 4 | EFO_0010091 | |
| Disease | aspartate aminotransferase measurement | TRIM46 MCMBP TRPM7 SLC26A2 CUBN ZNF827 FTO IL1RN NUP160 MOCOS SOS2 | 3.00e-03 | 904 | 135 | 11 | EFO_0004736 |
| Disease | skin pigmentation measurement | 3.68e-03 | 137 | 135 | 4 | EFO_0007009 | |
| Disease | haptoglobin measurement | 4.12e-03 | 21 | 135 | 2 | EFO_0004640 | |
| Disease | bone density, lean body mass | 4.12e-03 | 21 | 135 | 2 | EFO_0003923, EFO_0004995 | |
| Disease | temporal horn of lateral ventricle volume measurement | 4.44e-03 | 72 | 135 | 3 | EFO_0010333 | |
| Disease | Granulomatous Slack Skin | 4.52e-03 | 22 | 135 | 2 | C0376407 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TSAPVHLLIRCGFSS | 546 | Q96KV6 | |
| SFDLLTPHRCFSFTA | 451 | Q8WWN8 | |
| TRCSAIGFRLLHSPQ | 36 | Q9Y4M8 | |
| IPVHRQFGLSFESLC | 141 | P22674 | |
| FVFTRHSQTTAIPSC | 1446 | Q01955 | |
| FSETSTLGPKTFHRC | 341 | A4D0V7 | |
| KIHSTLTPCGTFLFA | 846 | Q8N157 | |
| CTTGRPNVSLSSFHI | 596 | Q96PE1 | |
| LSSTINPCGHLFRTA | 41 | Q9UIF8 | |
| IRCSHQPISLLGSFL | 456 | Q12774 | |
| LTQNSGFRLSSPHFL | 161 | Q496F6 | |
| LSHPSSGRSTFCSII | 256 | Q96L96 | |
| IRCSHQPISLLGSFL | 456 | A5YM69 | |
| QLTGCSRFGHIFPSS | 151 | Q6RI45 | |
| GCVAQPSSFLLNHTR | 371 | Q8N6Q3 | |
| SFHQGCTIASQRLTP | 146 | P32970 | |
| TVPCSTDFRGRFLSH | 41 | Q8WXS8 | |
| HLSSIGRSPVVFCDF | 886 | Q96MI9 | |
| EPGVQSCLTHFSLIT | 376 | Q6VUC0 | |
| SLSFELPRHTCSGLQ | 406 | O00189 | |
| SILHGPTFAACRSQV | 1086 | Q9HC84 | |
| VLPRQTCGLFTHTIF | 471 | O95803 | |
| HSLCFNFTIKSLSRP | 31 | Q8TD07 | |
| RVFHAITESGVSCPT | 436 | Q14644 | |
| GFQQRALCHALTFPS | 336 | Q96P11 | |
| PSGRTISFHSCVAQL | 86 | Q8NGN6 | |
| PSGRAISFHSCVAQL | 86 | Q8NGN3 | |
| VQSTLTLQLPFCGHR | 161 | Q8NGZ5 | |
| SILSVFPERLGFCQH | 266 | Q2Q1W2 | |
| IFCVIFLHGRNSPQS | 311 | Q9Y6Y0 | |
| RISLFGTFLFNSPHQ | 496 | Q9NXD2 | |
| QHCVLAGSQPRFSST | 306 | Q9C0B1 | |
| PIIHTSDGRCSISFS | 471 | Q8NBH2 | |
| SPGRTTQLFSLPCHR | 556 | P0C7T5 | |
| TVTGSGSCRHLQFIP | 706 | Q14118 | |
| HTTVTNSTPLRAACF | 116 | Q9UK73 | |
| IASGRLPCSFVTHAL | 321 | O43491 | |
| LIFTTGCLTYSPHQI | 351 | Q969U6 | |
| SAHFTVVTLFFGPCT | 241 | Q96R72 | |
| TAHITVVTLFFGPCI | 241 | Q8NH41 | |
| IQASSIFRLHFCGPN | 161 | Q8NGJ0 | |
| RCQSFLSFFTPSTLG | 61 | P01213 | |
| LCHSASLSSATVPRF | 296 | Q08493 | |
| QTHTAASFRLPAFVG | 561 | P39060 | |
| CSQSTPISGFHQTRI | 771 | Q8IXT1 | |
| IRCRFSPIHSTGQQF | 441 | Q8TEB1 | |
| RHPNTLSFRCSLADF | 31 | Q9HC98 | |
| TFFGRPCHLIKQSSN | 696 | Q96EN8 | |
| GNCSLLSVFSLVRPH | 246 | Q02153 | |
| LSGSQLRRFPLHVCS | 36 | Q5BKY1 | |
| TCPSFTRLSFHSAVV | 21 | Q8WWY8 | |
| GSIFFPHCNSASTRI | 106 | Q05C16 | |
| SFSFPCHQTGLDRST | 166 | P52790 | |
| CFSSPNFLHQSRALL | 356 | Q8TDS5 | |
| FPVVFSGLFSSHLCA | 141 | Q8IV76 | |
| FGSKHVSPRTLTSCF | 106 | P25205 | |
| SAFQLGRFCGSSLPH | 541 | O60494 | |
| LLSTHVQGFFTSCLR | 1861 | Q13315 | |
| DVSFGFPHTLICSLN | 576 | Q4G0P3 | |
| NISGCAVSPAIHFSF | 4301 | Q4G0P3 | |
| TSCLQSITPHFIAGE | 86 | Q8WXQ3 | |
| PTLQSSTGCFTRLAH | 516 | Q9UKA2 | |
| STGCFTRLAHQLPNL | 521 | Q9UKA2 | |
| FPVCAHRETTIVSFG | 141 | O75508 | |
| AVFCLFLSGFPTTHA | 11 | P12111 | |
| SGFSLQSCRHSIPVF | 276 | P03951 | |
| LVFTGAPHISDCTFR | 381 | Q8NEE6 | |
| HPSSAFLNLIGFVSR | 31 | P53004 | |
| FLCFSSSHLIQGQLP | 931 | A0A0U1RQI7 | |
| LFLFHSETICRPSGR | 16 | P18510 | |
| TSCAFPGLISTHSKF | 551 | Q6UWX4 | |
| LTHPANRSCRETGSF | 281 | Q8IZD6 | |
| HIFCTRRAINLGFPS | 51 | Q6ZPB5 | |
| RELLTFFCTNATIHG | 221 | P51172 | |
| QTEGCIFPLHTSVTL | 21 | Q8NEC7 | |
| AHSVVPISCFLRQGS | 66 | Q6ZQY2 | |
| VNLSGCPRNSTFTEH | 391 | Q9BTE3 | |
| GCPTVTHNFTRSGTF | 1341 | P98161 | |
| PSGRAISFHSCVAQL | 86 | Q8NGN4 | |
| LPSTVGFINHDCTRV | 51 | Q3SX64 | |
| FSAPLATVLSNRFGH | 76 | O15403 | |
| HTALIATGCFIFLTP | 196 | P58170 | |
| GQSKAFSTCFPHLTV | 231 | Q96R54 | |
| LVCSRGRLNSHPIFS | 891 | P11717 | |
| CETIGVFSPSSHSFL | 266 | Q9NYV9 | |
| FPSCHSFILILGNSK | 276 | Q7RTR8 | |
| AIGFSCSSAHPFILI | 266 | P59539 | |
| PFVFTQGHSVCNRSF | 191 | Q9HAU8 | |
| LQTFRPAASSSFRHC | 396 | Q7Z4K8 | |
| VLLPHSKSFFSSCGS | 1121 | Q07890 | |
| NFLTDLPGCSHFSRL | 476 | Q9BXR5 | |
| LPGCSHFSRLSVLNI | 481 | Q9BXR5 | |
| HRFQPVAVSSNGLFC | 591 | Q9UI40 | |
| RCHGPPIRFTTVFSN | 406 | Q969Y0 | |
| ILTSRHTPFQRGVFC | 26 | O14494 | |
| RTRSCPAFSTQGEFH | 791 | Q9H2Y9 | |
| QLPVTHLFSFGLSSR | 466 | Q75T13 | |
| PLLSFTQNIAHSCTR | 2356 | P08F94 | |
| NHPFFTISCITLIGL | 66 | Q8N9A8 | |
| HAGTQVFLCSLFAPV | 106 | Q8N474 | |
| PRHFREFTVCSIGTA | 56 | Q12769 | |
| LCALLSSNPNFHFTG | 1066 | Q13018 | |
| SGLSSTTLPRFHQAF | 481 | Q9UPG8 | |
| FFGTAVTCLLSPHSQ | 416 | Q5JTH9 | |
| VAHGCSVTLFLFPSQ | 626 | O94855 | |
| NIASGCPRFVAHSVL | 516 | O00463 | |
| NNVFVTHRSLSGCPL | 881 | O60284 | |
| HLTRLLFASGFNFPC | 191 | Q8TDG2 | |
| IVGSSRVCFAQHTPS | 726 | P51790 | |
| VHCFSSSLRGTFGTR | 21 | Q8IYJ2 | |
| NSTFTFTTCRILHPS | 666 | Q9UPV9 | |
| LGNTSFTDFSCKHPR | 3206 | A4UGR9 | |
| SHCAFQGALRPVFSL | 396 | Q8N7C3 | |
| FTFTTCRILHPSDIT | 671 | O60296 | |
| TITLHGPFFSSFACV | 201 | Q9Y4E5 | |
| VSHPCTGTTFRVLSD | 1551 | Q96KV7 | |
| STCLLSRFSVGIFHL | 436 | Q9BSA9 | |
| FSLPSVVFTRGIFCH | 161 | Q9HAW8 | |
| GILLTLPHFFCFSTT | 386 | Q7RTY0 | |
| AFLVLHSRFCGSPVL | 16 | Q5JS37 | |
| HSRFCGSPVLRNFTF | 21 | Q5JS37 | |
| RRCSLHPTPTSGLFQ | 1116 | Q6ZVD8 | |
| SVVCHTPLNNLGFSR | 431 | Q8WVR3 | |
| IIPSFFHCFTTSAAL | 426 | P50443 | |
| FSLPLFFIGCSSHQI | 456 | O94956 | |
| GFQSHRPRTTVCALS | 761 | Q7L0X0 | |
| PVCTLVSSHNVLFSG | 481 | Q6Q0C0 | |
| PSLHSLCQFRVATQG | 531 | Q9C0B7 | |
| FSLPSVVFARGILCH | 161 | O60656 | |
| FGRTLCDSSSLLFHQ | 251 | Q06730 | |
| QLCPFTSSRHFSLKL | 436 | Q17R98 | |
| LTCSRPFTRHQSFGL | 131 | Q6ZNB5 | |
| LTCVFSTLGSPDHFR | 991 | Q70CQ2 | |
| VHISSLRSVCFSPEG | 291 | Q9NYS7 | |
| GHFQTVASCVFLPRA | 276 | Q8NA23 | |
| LQSFLPCFDHIFTTG | 106 | O15050 | |
| PRALLFGHTASITCL | 56 | Q9Y4E6 | |
| PGFTFASLRARTCHV | 301 | Q9H091 | |
| SGCFSTFQPTTGHRL | 46 | Q96EK4 | |
| LSPISHGNTIALFFR | 601 | Q9BQ70 | |
| SSLAGFTDCHRTSIP | 1476 | Q96QT4 | |
| FSLPSVVFARGIFCH | 161 | Q9HAW7 | |
| RTFPNNKHFTCPTSS | 676 | Q9BYX2 | |
| FSLPSVVFARGIACH | 161 | Q9HAW9 | |
| LAHRAVLASCSPFFQ | 86 | Q9H5J0 | |
| QASSNPFLVGLHSCF | 306 | Q05513 | |
| PFLVGLHSCFQTTSR | 311 | Q05513 | |
| AHRFGNATLFSLTTC | 191 | Q96L15 | |
| SFLTHRSLSGCPRAT | 1021 | Q9UL68 | |
| FLTHRSLSGCPRATF | 961 | Q01538 | |
| SSFRGHTPLDLTCST | 726 | Q00653 |